The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements
Open accessAbstract
Colorectal cancer (CRC), the third most common type of cancer, is the second leading cause of cancer-related mortality rates worldwide. Although modern research was able to shed light on the pathogenesis of CRC and provide enhanced screening strategies, the prevalence of CRC is still on the rise. Studies showed several cellular signaling pathways dysregulated in CRC, leading to the onset of malignant phenotypes. Therefore, analyzing signaling pathways involved in CRC metastasis is necessary to elucidate the underlying mechanism of CRC progression and pharmacotherapy. This review focused on target genes as well as various cellular signaling pathways including Wnt/β-catenin, p53, TGF-β/SMAD, NF-κB, Notch, VEGF, and JAKs/STAT3, which are associated with CRC progression and metastasis. Additionally, alternations in methylation patterns in relation with signaling pathways involved in regulating various cellular mechanisms such as cell cycle, transcription, apoptosis, and angiogenesis as well as invasion and metastasis were also reviewed. To date, understanding the genomic and epigenomic instability has identified candidate biomarkers that are validated for routine clinical use in CRC management. Nevertheless, better understanding of the onset and progression of CRC can aid in the development of early detection molecular markers and risk stratification methods to improve the clinical care of CRC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Giantonio, B. J., Catalano, P. J., Meropol, N. J., O'Dwyer, P. J., Mitchell, E. P., Alberts, S. R., Schwartz, M. A., & Benson, A. B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6305 · Cited by 2,279
The Clinical KRAS(G12C) Inhibitor AMG 510 Drives Anti-Tumour Immunity
Canon, J., Rex, K., Saiki, A. Y., Mohr, C., Cooke, K., Bagal, D., Gaida, K., Holt, T., Knutson, C. G., Koppada, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1694-1 · Cited by 2,277 · cited 1×
“AMG 510 specifically and irreversibly blocks KRASG12 C by locking it in the inactive GDP-bound state [211].”
BackgroundInactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Prahallad, A., Sun, C., Huang, S., Di Nicolantonio, F., Salazar, R., Zecchin, D., Beijersbergen, R. L., Bardelli, A., & Bernards, R. (2012) · Nature · doi:10.1038/nature10868 · Cited by 2,051
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Cetuximab for the Treatment of Colorectal Cancer
Jonker, D. J., O'Callaghan, C. J., Karapetis, C. S., Zalcberg, J. R., Tu, D., Au, H.-J., Berry, S. R., Krahn, M., Price, T., Simes, R. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071834 · Cited by 1,904
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., van Boom, J. H., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
Douillard, J.-Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4860 · Cited by 1,809
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis
Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., & Offerhaus, G. J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281805 · Cited by 1,717
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543
Cetuximab in the treatment of colorectal cancer.
Goldberg, R. M., Venook, A. P., & Schilsky, R. L. (2004) · PubMed · Cited by 1,518
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
Kopetz, S., Grothey, A., Yaeger, R., Van Cutsem, E., Desai, J., Yoshino, T., Wasan, H., Ciardiello, F., Loupakis, F., Hong, Y. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908075 · Cited by 1,491
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
The Ras superfamily at a glance
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01660 · Cited by 1,352
Hallin, J., Engstrom, L. D., Hargis, L., Calinisan, A., Aranda, R., Briere, D. M., Sudhakar, N., Bowcut, V., Baer, B. R., Ballard, J. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1167 · Cited by 1,304
Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor
Janes, M. R., Zhang, J., Li, L.-S., Hansen, R., Peters, U., Guo, X., Chen, Y., Babbar, A., Firdaus, S. J., Darjania, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.006 · Cited by 1,172
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Akt, FoxO and regulation of apoptosis
Zhang, X., Tang, N., Hadden, T. J., & Rishi, A. K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.010 · Cited by 1,103
Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
Forrester, K., Almoguera, C., Han, K., Grizzle, W. E., & Perucho, M. (1987) · Nature · doi:10.1038/327298a0 · Cited by 1,061
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Arteaga, C. L., & Engelman, J. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.025 · Cited by 1,048 · cited 3×
“EGFR-KRAS-BRAF Pathway The epidermal growth factor receptor (EGFR) belongs to the ErbB/HER family and consists of four members; ErbB1 (EGFR/HER1), ErbB2 (Neu/HER2), ErbB3 (HER3), and ErbB4 (HER4) [146,147].”
BackgroundCorcoran, R. B., Ebi, H., Turke, A. B., Coffee, E. M., Nishino, M., Cogdill, A. P., Brown, R. D., Della Pelle, P., Dias-Santagata, D., Hung, K. E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0341 · Cited by 1,022
The Chromosomal Instability Pathway in Colon Cancer
Pino, M. S., & Chung, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.065 · Cited by 932
Venook, A. P., Niedzwiecki, D., Lenz, H.-J., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7105 · Cited by 898 · cited 1×
“Furthermore, KRAS-mutant patients were also found to benefit from bevacizumab [225,226].”
BackgroundRas in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Fearnhead, N. S. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.721 · Cited by 882
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in MYH
Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K. S., Bisgaard, M.-L., Orntoft, T. F., Aaltonen, L. A., Hodgson, S. V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025283 · Cited by 862
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80128-2 · Cited by 845
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration
Sansom, O. J., Reed, K. R., Hayes, A. J., Ireland, H., Brinkmann, H., Newton, I. P., Batlle, E., Simon-Assmann, P., Clevers, H., Nathke, I. S., et al. (2004) · Genes & Development · doi:10.1101/gad.287404 · Cited by 799
Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
Parsons, R. E., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 738
Allelic Loss of Chromosome 18q and Prognosis in Colorectal Cancer
Jen, J., Kim, H., Piantadosi, S., Liu, Z.-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., & Hamilton, S. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407283310401 · Cited by 696
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I. F., Silver, S. J., Guney, I., Freed, E., Ligon, A. H., Vena, N., Ogino, S., et al. (2008) · Nature · doi:10.1038/nature07179 · Cited by 672
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
Sigal, A., & Rotter, V. (2000) · PubMed · Cited by 666
Signal transduction through beta-catenin and specification of cell fate during embryogenesis.
Miller, J. R., & Moon, R. T. (1996) · Genes & Development · doi:10.1101/gad.10.20.2527 · Cited by 656
Schwartzberg, L. S., Rivera, F., Karthaus, M., Fasola, G., Canon, J.-L., Hecht, J. R., Yu, H., Oliner, K. S., & Go, W. Y. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.2473 · Cited by 635
Mastermind Recruits CycC:CDK8 to Phosphorylate the Notch ICD and Coordinate Activation with Turnover
Fryer, C. J., White, J. B., & Jones, K. A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.014 · Cited by 627
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
Thiagalingam, S., Lengauer, C., Leach, F. S., Schutte, M., Hahn, S. A., Overhauser, J., Willson, J. K. V., Markowitz, S., Hamilton, S. R., Kern, S. E., et al. (1996) · Nature Genetics · doi:10.1038/ng0796-343 · Cited by 617
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Douillard, J. Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu141 · Cited by 606
Molecular Diagnosis of Familial Adenomatous Polyposis
Powell, S. M., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292702 · Cited by 599
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer
Corcoran, R. B., André, T., Atreya, C. E., Schellens, J. H. M., Yoshino, T., Bendell, J. C., Hollebecque, A., McRee, A. J., Siena, S., Middleton, G., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1226 · Cited by 592
Lito, P., Pratilas, C. A., Joseph, E. W., Tadi, M., Halilovic, E., Zubrowski, M., Huang, A., Wong, W. L., Callahan, M. K., Merghoub, T., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.009 · Cited by 562
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
A role for the Adenomatous Polyposis Coli protein in chromosome segregation
Kaplan, K. B., Burds, A. A., Swedlow, J. R., Bekir, S. S., Sorger, P. K., & Näthke, I. S. (2001) · Nature Cell Biology · doi:10.1038/35070123 · Cited by 545
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer
Smith, G., Carey, F. A., Beattie, J., Wilkie, M. J. V., Lightfoot, T. J., Coxhead, J., Garner, R. C., Steele, R. J. C., & Wolf, C. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122612899 · Cited by 521
Simkens, L. H. J., van Tinteren, H., May, A., ten Tije, A. J., Creemers, G.-J. M., Loosveld, O. J. L., de Jongh, F. E., Erdkamp, F. L. G., Erjavec, Z., van der Torren, A. M. E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62004-3 · Cited by 517
O'Brien, M. J., Yang, S., Mack, C., Xu, H., Huang, C. S., Mulcahy, E., Amorosino, M., & Farraye, F. A. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213313.36306.85 · Cited by 509
Rowan, A. J., Lamlum, H., Ilyas, M., Wheeler, J., Straub, J., Papadopoulou, A., Bicknell, D., Bodmer, W. F., & Tomlinson, I. P. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3352 · Cited by 500
Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene
Aoki, K., & Taketo, M. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03485 · Cited by 492
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.014 · Cited by 487
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485
Näthke, I. S., Adams, C. L., Polakis, P., Sellin, J. H., & Nelson, W. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.1.165 · Cited by 484
Price, T. J., Peeters, M., Kim, T. W., Li, J., Cascinu, S., Ruff, P., Suresh, A. S., Thomas, A., Tjulandin, S., Zhang, K., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70118-4 · Cited by 473
Targeting the ERBB family in cancer: couples therapy
Tebbutt, N., Pedersen, M. W., & Johns, T. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3559 · Cited by 466
p21 and p27: roles in carcinogenesis and drug resistance
Abukhdeir, A. M., & Park, B. H. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000744 · Cited by 463
A structural basis for mutational inactivation of the tumour suppressor Smad4
Shi, Y., Hata, A., Lo, R. S., Massagué, J., & Pavletich, N. P. (1997) · Nature · doi:10.1038/40431 · Cited by 461
Genetic alterations in colorectal cancer.
Armaghany, T., Wilson, J. D., Chu, Q., & Mills, G. M. (2012) · Europe PMC (PubMed Central) · Cited by 456
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Hsu, J. L., & Hung, M.-C. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9649-6 · Cited by 445
Wang, Z. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7219-7_1 · Cited by 430
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429
APC gene: database of germline and somatic mutations in human tumors and cell lines
Beroud, C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.121 · Cited by 420
Sheffer, M., Bacolod, M. D., Zuk, O., Giardina, S. F., Pincas, H., Barany, F., Paty, P. B., Gerald, W. L., Notterman, D. A., & Domany, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902232106 · Cited by 414
WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription
Chen, S., Guttridge, D. C., You, Z., Zhang, Z., Fribley, A., Mayo, M. W., Kitajewski, J., & Wang, C.-Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.1.87 · Cited by 394
Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters
Shen, L., Kondo, Y., Guo, Y., Zhang, J., Zhang, L., Ahmed, S., Shu, J., Chen, X., Waterland, R. A., & Issa, J.-P. J. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030181 · Cited by 389
Kopetz, S., Guthrie, K. A., Morris, V. K., Lenz, H.-J., Magliocco, A. M., Maru, D., Yan, Y., Lanman, R., Manyam, G., Hong, D. S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01994 · Cited by 389
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
Neumann, J., Zeindl-Eberhart, E., Kirchner, T., & Jung, A. (2009) · Pathology - Research and Practice · doi:10.1016/j.prp.2009.07.010 · Cited by 361
Ogino, S., Cantor, M., Kawasaki, T., Brahmandam, M., Kirkner, G. J., Weisenberger, D. J., Campan, M., Laird, P. W., Loda, M., & Fuchs, C. S. (2006) · Gut · doi:10.1136/gut.2005.082933 · Cited by 359
Multistage carcinogenesis and the incidence of colorectal cancer
Luebeck, E. G., & Moolgavkar, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222118199 · Cited by 358
Jones, J. C., Renfro, L. A., Al-Shamsi, H. O., Schrock, A. B., Rankin, A., Zhang, B. Y., Kasi, P. M., Voss, J. S., Leal, A. D., Sun, J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.4394 · Cited by 339
Cancer in inflammatory bowel disease
Xie, J., & Itzkowitz, S. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.378 · Cited by 328
SMAD2,SMAD3 and SMAD4 Mutations in Colorectal Cancer
Fleming, N. I., Jorissen, R. N., Mouradov, D., Christie, M., Sakthianandeswaren, A., Palmieri, M., Day, F., Li, S., Tsui, C., Lipton, L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2706 · Cited by 324
Netrin-1 controls colorectal tumorigenesis by regulating apoptosis
Mazelin, L., Bernet, A., Bonod-Bidaud, C., Pays, L., Arnaud, S., Gespach, C., Bredesen, D. E., Scoazec, J.-Y., & Mehlen, P. (2004) · Nature · doi:10.1038/nature02788 · Cited by 321
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
Zhao, B., Wang, L., Qiu, H., Zhang, M., Sun, L., Peng, P., Yu, Q., & Yuan, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14012 · Cited by 319
GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
Grady, W. M., & Markowitz, S. D. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103043 · Cited by 316
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
Arber, N., Hibshoosh, H., Moss, S., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I., & Holt, P. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608874 · Cited by 313
Leary, R. J., Lin, J. C., Cummins, J., Boca, S., Wood, L. D., Parsons, D. W., Jones, S., Sjöblom, T., Park, B.-H., Parsons, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808041105 · Cited by 306
O’Neil, B. H., Wallmark, J. M., Lorente, D., Elez, E., Raimbourg, J., Gomez-Roca, C., Ejadi, S., Piha-Paul, S. A., Stein, M. N., Abdul Razak, A. R., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189848 · Cited by 296
The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction
Nilsson, J., Yekezare, M., Minshull, J., & Pines, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1799 · Cited by 295
[Genetic alterations in colorectal cancer].
Laurent‐Puig, P. (1994) · PubMed · Cited by 293
Notch post-translationally regulates β-catenin protein in stem and progenitor cells
Kwon, C., Cheng, P., King, I. N., Andersen, P., Shenje, L., Nigam, V., & Srivastava, D. (2011) · Nature Cell Biology · doi:10.1038/ncb2313 · Cited by 284
Endometrial Cancer and Lynch Syndrome: Clinical and Pathologic Considerations
Meyer, L. A., Broaddus, R. R., & Lu, K. H. (2009) · Cancer Control · doi:10.1177/107327480901600103 · Cited by 281
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
Conlin, A., Smith, G., Carey, F. A., Wolf, C. R., & Steele, R. J. C. (2005) · Gut · doi:10.1136/gut.2005.066514 · Cited by 261
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
Liu, Y., & Bodmer, W. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510146103 · Cited by 257
Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas
Cottrell, S., Bodmer, W. F., Bicknell, D., & Kaklamanis, L. (1992) · The Lancet · doi:10.1016/0140-6736(92)92169-g · Cited by 251
The molecular genetics of colorectal cancer
Ewing, I., Hurley, J. J., Josephides, E., & Millar, A. (2014) · Frontline Gastroenterology · doi:10.1136/flgastro-2013-100329 · Cited by 249
Imamura, Y., Morikawa, T., Liao, X., Lochhead, P., Kuchiba, A., Yamauchi, M., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., Haigis, K. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3210 · Cited by 249
Long, G. V., Atkinson, V., Cebon, J. S., Jameson, M. B., Fitzharris, B. M., McNeil, C. M., Hill, A. G., Ribas, A., Atkins, M. B., Thompson, J. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30428-x · Cited by 245
Phipps, A. I., Buchanan, D. D., Makar, K. W., Win, A. K., Baron, J. A., Lindor, N. M., Potter, J. D., & Newcomb, P. A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.118 · Cited by 238
van Geel, R. M. J. M., Tabernero, J., Elez, E., Bendell, J. C., Spreafico, A., Schuler, M., Yoshino, T., Delord, J.-P., Yamada, Y., Lolkema, M. P., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0795 · Cited by 232
Cancer of the microsatellite mutator phenotype.
Perucho, M. (1996) · PubMed · Cited by 227
BUB1 and BUBR1: multifaceted kinases of the cell cycle
Bolanos-Garcia, V. M., & Blundell, T. L. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.004 · Cited by 223
Hong, D. S., Morris, V. K., El Osta, B., Sorokin, A. V., Janku, F., Fu, S., Overman, M. J., Piha-Paul, S., Subbiah, V., Kee, B., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0050 · Cited by 219
Akt/Protein Kinase B Isoforms Are Differentially Regulated by Epidermal Growth Factor Stimulation
Okano, J.-I., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K., & Nakagawa, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004112200 · Cited by 213
Dihlmann, S., Siermann, A., & von Knebel Doeberitz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204123 · Cited by 199
Molecular genetics of colorectal cancer.
Bogaert, J. A., & Prenen, H. (2014) · PubMed Central · Cited by 185
Berlin, J., Bendell, J. C., Hart, L. L., Firdaus, I., Gore, I., Hermann, R. C., Mulcahy, M. F., Zalupski, M. M., Mackey, H. M., Yauch, R. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1800 · Cited by 181
Diep, C. B., Kleivi, K., Ribeiro, F. R., Teixeira, M. R., Lindgjærde, O. C., & Lothe, R. A. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20261 · Cited by 178
Domingo, E., Niessen, R. C., Oliveira, C., Alhopuro, P., Moutinho, C., Espín, E., Armengol, M., Sijmons, R. H., Kleibeuker, J. H., Seruca, R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208569 · Cited by 177
Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability
Shin, H.-J., Baek, K.-H., Jeon, A.-H., Park, M.-T., Lee, S.-J., Kang, C.-M., Lee, H.-S., Yoo, S.-H., Chung, D.-H., Sung, Y.-C., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00302-7 · Cited by 172
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.
Baeg, G. H., Matsumine, A., Kuroda, T., Bhattacharjee, R. N., Miyashiro, I., Toyoshima, K., & Akiyama, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00249.x · Cited by 171
Christie, M., Jorissen, R. N., Mouradov, D., Sakthianandeswaren, A., Li, S., Day, F. L., Tsui, C. S., Lipton, L. R., Desai, J., Jones, I. T., et al. (2012) · Oncogene · doi:10.1038/onc.2012.486 · Cited by 169
Cremolini, C., Bartolomeo, M. D., Amatu, A., Antoniotti, C., Moretto, R., Berenato, R., Perrone, F., Tamborini, E., Aprile, G., Lonardi, S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv290 · Cited by 167
Passardi, A., Nanni, O., Tassinari, D., Turci, D., Cavanna, L., Fontana, A., Ruscelli, S., Mucciarini, C., Lorusso, V., Ragazzini, A., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv130 · Cited by 163
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
Caputo, F., Santini, C., Bardasi, C., Cerma, K., Casadei-Gardini, A., Spallanzani, A., Andrikou, K., Cascinu, S., & Gelsomino, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215369 · Cited by 162
Wirtzfeld, D. A., Petrelli, N. J., & Rodriguez-Bigas, M. A. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0319-7 · Cited by 158
Sekiya, T., Adachi, S., Kohu, K., Yamada, T., Higuchi, O., Furukawa, Y., Nakamura, Y., Nakamura, T., Tashiro, K., Kuhara, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310876200 · Cited by 158
Role of the Dependence Receptor DCC in Colorectal Cancer Pathogenesis
Mehlen, P., & Fearon, E. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.019 · Cited by 154
The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
Amelio, I., & Melino, G. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.04.007 · Cited by 153
Microsatellite Instability and Colorectal Cancer
Geiersbach, K. B., & Samowitz, W. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0035-ra · Cited by 153
Mori, Y., Yin, J., Rashid, A., Leggett, B., Young, J. P., Simms, L. A., Kuehl, P. M., LANGENBERG, P. W., Meltzer, S. J., & Stine, O. C. (2001) · PubMed · Cited by 150
A phase II study of RO4929097 in metastatic colorectal cancer
Strosberg, J., Yeatman, T. J., Weber, J., Coppola, D., Schell, M. J., Han, G., Almhanna, K., Kim, R. D., Valone, T., Jump, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.056 · Cited by 148
Velho, S., Moutinho, C., Cirnes, L., Albuquerque, C. M., Hamelin, R., Schmitt, F. C., Carneiro, F., Oliveíra, C., & Seruca, R. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-255 · Cited by 145
Baudis, M. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-226 · Cited by 145
Human cancers converge at the HIF-2α oncogenic axis
Franovic, A., Holterman, C. E., Payette, J., & Lee, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906432106 · Cited by 135
Cyclooxygenase-2 Inhibition Inhibits c-Met Kinase Activity and Wnt Activity in Colon Cancer
Tuynman, J. B., Vermeulen, L., Boon, E. M. J., Kemper, K., Zwinderman, A. H., Peppelenbosch, M. P., & Richel, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5172 · Cited by 134
Tosi, F., Magni, E., Amatu, A., Mauri, G., Bencardino, K. B., Truini, M., Veronese, S. M., Carlis, L. G. D., Ferrari, G. C., Nichelatti, M., et al. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.01.004 · Cited by 124
Wirtzfeld, D. A. (2001) · Annals of Surgical Oncology · doi:10.1245/aso.2001.8.4.319 · Cited by 124
Zheng, H., Pritchard, D. M., Yang, X., Bennett, E., Liu, G., Liu, C., & Ai, W. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90393.2008 · Cited by 122
Ogino, S., Nosho, K., Irahara, N., Shima, K., Baba, Y., Kirkner, G. J., Meyerhardt, J. A., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8858 · Cited by 121
Rigal, M., Kevei, Z., Pélissier, T., & Mathieu, O. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.141 · Cited by 120
Pronobis, M. I., Rusan, N. M., & Peifer, M. A. (2015) · eLife · doi:10.7554/elife.08022 · Cited by 120
Vecchione, L., Jacobs, B., Normanno, N., Ciardiello, F., & Tejpar, S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.021 · Cited by 119
He, L., Lu, N., Dai, Q., Zhao, Y., Zhao, L., Wang, H., Li, Z., You, Q., & Guo, Q. (2013) · Toxicology · doi:10.1016/j.tox.2013.07.013 · Cited by 118
The Wnt signaling pathway: a potential therapeutic target against cancer
Ghosh, N., Hossain, U., Mandal, A., & Sil, P. C. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14027 · Cited by 118
Yarom, N., & Jonker, D. J. (2011) · PubMed · Cited by 110
Ogino, S., Kawasaki, T., Kirkner, G. J., Suemoto, Y., Meyerhardt, J. A., & Fuchs, C. S. (2007) · Gut · doi:10.1136/gut.2007.119750 · Cited by 108
Suzuki, H., Igarashi, S., Nojima, M., Maruyama, R., Yamamoto, E., Kai, M., Akashi, H., Watanabe, Y., Yamamoto, H., Sasaki, Y., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp179 · Cited by 107
Yu, X., Huang, X. B., Chen, X., Liu, J., Wu, C., Pu, Q., Wang, Y., Kang, X., & Zhou, L. (2019) · mAbs · doi:10.1080/19420862.2019.1629239 · Cited by 107
Park, S.-H., Cui, J., Yu, W., Wu, L., Carmon, K. S., & Liu, Q. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002743 · Cited by 102
Kopetz, S., McDonough, S. L., Morris, V. K., Lenz, H., Magliocco, A. M., Atreya, C. E., Diaz, L. A., Allegra, C. J., Wang, S. E., Lieu, C. H., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.35.4_suppl.520 · Cited by 102
Wei, W., Chua, M., Grepper, S., & So, S. K. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-16 · Cited by 101
Biological significance of the CpG island methylator phenotype
Suzuki, H., Yamamoto, E., Maruyama, R., Niinuma, T., & Kai, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.007 · Cited by 99
Tabernero, J. M., van Geel, R. M. J. M., Guren, T. K., Yaeger, R. D., Spreafico, A., Faris, J. E., Yoshino, T., Yamada, Y., Kim, T. W., Bendell, J. C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.3544 · Cited by 99
Frequency and Type of KRAS Mutations in Routine Diagnostic Analysis of Metastatic Colorectal Cancer
Neumann, J. H. L., Zeindl‐Eberhart, E., Kirchner, T., & Jung, A. (2009) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0029-1242277 · Cited by 98
Epigenetic events in the colorectum and in colon cancer
Grady, W. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330684 · Cited by 97
Marchand, L. L., Wilkens, L. R., Hankin, J. H., Kolonel, L. N., & Lyu, L.-C. (1997) · Cancer Causes & Control · doi:10.1023/a:1018406716115 · Cited by 92
Pode‐Shakked, N., Harari‐Steinberg, O., Haberman-Ziv, Y., Rom‐Gross, E., Bahar, S., Omer, D. S., Metsuyanim, S., Buzhor, E., Jacob–Hirsch, J., Goldstein, R. S., et al. (2011) · Oncogene · doi:10.1038/onc.2010.549 · Cited by 89
Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
Zhou, E., Huang, Q. B., Wang, J., Fang, C., Yang, L., Zhu, M., Chen, J., Chen, L., & Dong, M. (2015) · PubMed · Cited by 86
Ogino, S., Brahmandam, M., Kawasaki, T., Kirkner, G. J., Loda, M. F., & Fuchs, C. S. (2006) · Neoplasia · doi:10.1593/neo.06247 · Cited by 84
Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas
Ishiguro, K., Yoshida, T., Yagishita, H., Numata, Y., & Okayasu, T. (2005) · Gut · doi:10.1136/gut.2005.079459 · Cited by 83
Lavergne, E., Hendaoui, I., Coulouarn, C., Ribault, C., Leseur, J., Eliat, P., Mebarki, S., Corlu, A., Clément, B., & Musso, O. C. (2010) · Oncogene · doi:10.1038/onc.2010.432 · Cited by 81
Heinen, C. D., Goss, K. H., Cornelius, J. R., Babcock, G. F., Knudsen, E. S., Kowalik, T. F., & Groden, J. L. (2002) · Gastroenterology · doi:10.1053/gast.2002.35382 · Cited by 81
Targeting Angiogenesis in Colorectal Carcinoma
Lopez, A., Harada, K., Vassilakopoulou, M., Shanbhag, N. D., & Ajani, J. A. (2019) · Drugs · doi:10.1007/s40265-018-1037-9 · Cited by 81
Boulay, J.-L., Mild, G., Lowy, A. J., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U. T., Herrmann, R., & Rochlitz, C. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600511 · Cited by 79
Colorectal cancer: epigenetic alterations and their clinical implications
Puccini, A., Berger, M. D., Naseem, M., Tokunaga, R., Battaglin, F., Cao, S., Hanna, D. L., McSkane, M., Soni, S., Zhang, W., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.003 · Cited by 79
Vascular endothelial growth factor in colorectal cancer
Guba, M. O., Seeliger, H., Kleespies, A., Jauch, K., & Bruns, C. J. (2004) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0576-y · Cited by 76
Kosmidou, V., Oikonomou, E., Vlassi, M., Avlonitis, S., Katseli, A., Tsipras, I., Mourtzoukou, D., Kontogeorgos, G., Zografos, G., & Pintzas, A. (2013) · Human Mutation · doi:10.1002/humu.22496 · Cited by 74
Lenz, H., Cutsem, E. V., Limón, M., Wong, K., Hendlisz, A., Aglietta, M., García-Alfonso, P., Neyns, B., Luppi, G., Cardin, D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy424.019 · Cited by 71
Takayama, O., Yamamoto, H., Damdinsuren, B., Sugita, Y., Ngan, C. Y., Xu, X., Tsujino, T., Takemasa, I., Ikeda, M., Sekimoto, M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603343 · Cited by 69
Transcriptional Control of BubR1 by p53 and Suppression of Centrosome Amplification by BubR1
Oikawa, T., Okuda, M., Ma, Z., Goorha, R. M., Tsujimoto, H., INOKUMA, H., & Fukasawa, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4046-4061.2005 · Cited by 68
Jeremy, J. Y., Thompson, C. S., Mikhailidis, D. P., & Dandona, P. (1985) · Diabetologia · doi:10.1007/bf00283145 · Cited by 65
Early cellular events in colorectal carcinogenesis
Renehan, A. G., O’Dwyer, S., Haboubi, N. Y., & Potten, C. S. (2002) · Colorectal Disease · doi:10.1046/j.1463-1318.2002.00336.x · Cited by 62
Current and future molecular diagnostics in colorectal cancer and colorectal adenoma
Tsang, H. F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3847 · Cited by 56
Chittenden, T. W., Howe, E., Culhane, A. C., Sultana, R., Taylor, J. M., Holmes, C. C., & Quackenbush, J. F. (2008) · Genomics · doi:10.1016/j.ygeno.2008.03.002 · Cited by 54
Loss of Heterozygosity and DNA Aneuploidy in Colorectal Adenocarcinoma
Lin, J.-K., Chang, S., Yang, Y., & Li, A. F. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.12.014 · Cited by 54
Jasmine, F., Rahaman, R. O., Dodsworth, C., Roy, S., Paul, R., Raza, M., Paul-Brutus, R., Kamal, M., Ahsan, H., & Kibriya, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031968 · Cited by 54
Zhou, D., Yang, L., Zheng, L., Ge, W., Li, D., Zhang, Y., Hu, X., Gao, Z., Xu, J., Huang, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053310 · Cited by 51
Nosho, K., Kawasaki, T., Chan, A. T., Ohnishi, M., Suemoto, Y., Kirkner, G. J., Fuchs, C. S., & Ogino, S. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03161.x · Cited by 51
Tasaki, T., Sohr, R., Xia, Z., Hellweg, R., Hörtnagl, H., Varshavsky, A. J., & Kwon, Y. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701894200 · Cited by 50
Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma
Cohen, Y., Merhavi-Shoham, E., Avraham, R. B., Frenkel, S., Pe’er, J., & Goldenberg‐Cohen, N. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2007.10.010 · Cited by 48
Oyanagi, H., Shimada, Y., Nagahashi, M., Ichikawa, H., Tajima, Y., Abe, K., Nakano, M., Kameyama, H., Takii, Y., Kawasaki, T., et al. (2019) · Histopathology · doi:10.1111/his.13805 · Cited by 47
Loss of SMAD4 protein expression in gastrointestinal and extra‐gastrointestinal carcinomas
Ritterhouse, L. L., Wu, E. Y., Kim, W. G., Dillon, D. A., Hirsch, M. S., Sholl, L. M., Agoston, A. T., Setia, N., Lauwers, G. Y., Park, D. Y., et al. (2019) · Histopathology · doi:10.1111/his.13894 · Cited by 47
Corcoran, R. B., André, T., Yoshino, T., Bendell, J. C., Atreya, C. E., Schellens, J. H. M., Ducreux, M. P., McRee, A. J., Siena, S., Middleton, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw370.04 · Cited by 46
Browne, S. J., MacFarlane, M., Cohen, G. M., & Paraskeva, C. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400331 · Cited by 44
DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications
González-Ramírez, I., García-Cuellar, C. M., Sánchez-Pérez, Y., & García, M. G. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01833.x · Cited by 39
Mendelsohn, J. M., Prewett, M. C., Rockwell, P., & Goldstein, N. I. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2491 · Cited by 36
Wu, P., Wee, P., Jiang, J., Chen, X., & Wang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041354 · Cited by 34
Genomic Instability and Radiation Risk in Molecular Pathways to Colon Cancer
Kaiser, J. C., Meckbach, R., & Jacob, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111024 · Cited by 33
Cited by
Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., et al. (2022) · Cancers · doi:10.3390/cancers14071732 · Cited by 920
NF‐κB signaling in inflammation and cancer
Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021) · MedComm · doi:10.1002/mco2.104 · Cited by 574
Clinical management of metastatic colorectal cancer in the era of precision medicine
Ciardiello, F., Ciardiello, D., Martini, G., Napolitano, S., Tabernero, J., & Cervantes, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21728 · Cited by 528
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review
Hossain, M. S., Kader, M. A., Goh, K. W., Islam, M., Khan, M. S., Harun-Ar Rashid, M., Ooi, D. J., Melo Coutinho, H. D., Al-Worafi, Y. M., Moshawih, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865801 · Cited by 346
The Role of p53 Signaling in Colorectal Cancer
Liebl, M. C., & Hofmann, T. G. (2021) · Cancers · doi:10.3390/cancers13092125 · Cited by 318
Metadata
- Authors
- Malki, A., ElRuz, R. A., Gupta, I., Allouch, A., Vranic, S., & Al Moustafa, A.-E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-24
- Volume
- 22
- Issue
- 1
- Pages
- 130
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3117886022
- Cited by
- 398
- References
- 223
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.